XHKG
1827
Market cap45mUSD
Jul 02, Last price
0.90HKD
Name
Miricor Enterprises Holdings Ltd
Chart & Performance
P/E
32.05
P/S
0.99
EPS
0.03
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
22.97%
Revenues
362m
-10.11%
Net income
11m
+6.07%
CFO
0k
-100.00%
Dividend
Sep 23, 20260.1 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Miricor Enterprises Holdings Limited, an investment holding company, provides non-surgical medical aesthetic, wellness beauty services, and skincare products in Hong Kong and Mainland China. It offers non-surgical medical aesthetic services, including injection procedures; and treatment services, as well as prescription and dispensing medical products. The company also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, and masks. In addition, it engages in the wholesale of skincare products; owns trademarks; and offers management services. Further, the company operates medical aesthetic centers under the CosMax+, XOVE, and VITAE brand names. Miricor Enterprises Holdings Limited was founded in 2009 and is headquartered in Central, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||